<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The milieu of the liver, and in particular hepatocyte-derived extracellular matrix (hECM), is a critical factor regulating development of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells </plain></SENT>
<SENT sid="1" pm="."><plain>The present study has investigated genes altered by hECM in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells and particularly by <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> chains of hepatocyte <z:chebi fb="0" ids="37396">proteoglycans</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Gene profiling analysis shows that after 2 days on hECM, 226 genes are up-regulated more than 2-fold in strongly metastatic SM cells, including genes involved in <z:mpath ids='MPATH_73'>growth arrest</z:mpath> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, signal transduction, cell migration, proliferation, communication and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, with activation of the erbB signaling network and p53 effectors </plain></SENT>
<SENT sid="3" pm="."><plain>Genes down-regulated by hECM include genes involved in lipogenesis and the S phase of the cell cycle </plain></SENT>
<SENT sid="4" pm="."><plain>Further studies exploring the kinetics of gene expression after 4 and 7 days culture on hECM show induction of EGF family members and of stem cell markers </plain></SENT>
<SENT sid="5" pm="."><plain>In particular, hECM, but not collagen, increases <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of HB-EGF and colon stem cell marker leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) </plain></SENT>
<SENT sid="6" pm="."><plain>Expression of these genes is not induced by hECM depleted of the <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> chains of <z:chebi fb="0" ids="37396">proteoglycans</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Lastly, a specific cell population positive for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell (<z:chebi fb="11" ids="17437,53115">CSC</z:chebi>) markers LGR5, epCAM and CD133, but negative for CD44, appears after 7 days culture on hECM, a population which is reduced by 50 % in cells grown on <z:chebi fb="0" ids="24500">heparan</z:chebi> sulfated-depleted hECM </plain></SENT>
<SENT sid="8" pm="."><plain>Collectively, the data suggest that hECM induces growth factors and receptors regulating proliferation of metastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in the liver and offers a growth advantage for specific populations expressing <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> markers </plain></SENT>
</text></document>